Compare IDEXX Laboratories, Inc. (IDXX) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Stanley Black & Decker, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $553.81 (market cap $44.48B), while Stanley Black & Decker, Inc. trades at $88.56 (market cap $13.60B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.3× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays a 3.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | SWK | |
|---|---|---|
Market Cap | $44.48B | $13.60B |
Sector | Health | — |
52-Week High | $766.68 | $94.12 |
52-Week Low | $520.87 | $62.12 |
Enterprise Value | $45.38B | $19.77B |
Dividend Yield | — | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Stanley Black & Decker (SWK) trades at $87.52, down 2.94% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company has beaten earnings estimates for the last three quarters, with Q2 2026 results expected soon. Revenue has stabilized around $15.1B in 2025, while net income improved to $402M. The stock carries a P/E of 36.95 and a dividend yield supported by recent payouts.
SWK shows operational resilience with consistent cash flow and debt reduction, but faces headwinds in Tools & Outdoor demand. Analyst sentiment is mixed with a consensus hold rating; the stock offers value and momentum potential amid ongoing cost-saving initiatives and aerospace growth, though high debt and consumer weakness pose risks to near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
